New Zealand's meningococcal B immunization program, which uses Chiron's MeNZBT
vaccine, has been extended following successful results. Speaking at a celebration
to mark the delivery of the three millionth vaccine dose, New Zealand minister
of health Pete Hodgson said that new data confirms that the end of the meningococcal
B epidemic is in sight.
Pharmaceutical Business Review